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Abstract To explore the structural basis required for the 
hoioenzyme formation of cAMP-dependent protein kinase, we 
have prepared rabbit anti-peptide antibodies that can block the 
holoenzyme formation without affecting the catalytic activity of 
the enzyme. The antibodies were raised against a specific site in 
the catalytic (C)-subunit, termed IDA (Inter-DFG-APE) region, 
which lies between the kinase subdomains VII and VIII. 
Although the C-subunit immunoprecipitated with anti-IDA 
antibodies could not form a stable complex with regulatory 
(R)-subunit, it was still susceptible to inhibition by the R-subunit 
or by PKI, a specific inhibitor peptide containing a pseudosub- 
strate site. These results indicate that there exists an IDA region- 
mediated interaction between the R- and C-subunits, which is 
distinct from that mediated through the substrate site and 
substrate binding site. In accordance with this idea, association 
of synthetic IDA peptides with the R-subunit was directly 
demonstrated by resonance mirror analysis. The calculated 
association constants of IDA peptides were high enough to 
suggest a possible involvement of the IDA region in the initial 
step of holoenzyme formation. 
Key words: cAMP-dependent protein kinase; Subunit 
interaction; Resonance mirror analysis 
1. Introduction 
cAMP-dependent protein kinase (PKA) exists as an inactive 
holoenzyme composed of a dimer of regulatory (R)-subunit 
and two catalytic (C)-subunits [1]. It is well established that 
binding of cAMP to the R-subunit leads to disassembly of the 
holoenzyme and release of catalytically active C-subunits. 
Although the molecular mechanism by which the C- and R- 
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subunits constitute the holoenzyme complex remains obscure, 
it has been shown that a protease-sensitive 'hinge' region in 
the R-subunit, which contains the substrate consensus e- 
quence of PKA, occupies the substrate binding site of the 
C-subunit in the holoenzyme [1]. Actually, type II R-subunit 
can be phosphorylated on the hinge region [2]. However, the 
substrate site in the R-subunit is unlikely to be the sole region 
of the interaction, because (1) the highest affinity of known 
peptide substrates for the C-subunit is in the micromolar 
range, whereas that of the R-subnit is in the subnanomolar 
range [3-5], and (2) a mutant R-subunit, in which two argi- 
nines in the substrate consensus equence are replaced by 
alanines, has been found to form a holoenzyme that can be 
dissociated by cAMP, although it is no longer a substrate for 
the C-subunit [6]. These reports suggest he presence of an 
additional interaction(s) between the R-and C-subunits which 
is distinct from that through the substrate site of the R-sub- 
unit. On the other hand, molecular biological studies on the 
C-subunit have identified several residues that influence the 
susceptibility to inhibition by the R-subunit [7,8], and some 
of them are mapped on the surface of the crystal structure of 
the C-subunit [9]. However, there is no direct biochemical 
evidence for the involvement of these residues in the complex 
formation with the R-subunit. 
In the previous study [10], we applied a biochemical ap- 
proach to investigate the regulatory interactions between the 
catalytic and regulatory domains of c-Src, a member of the 
Src family protein-tyrosine kinases. It was found that the 
kinase activity of c-Src is regulated by an intramolecular in- 
teraction between the inhibitory region in the regulatory do- 
main and a region in the catalytic domain, named the IDA 
(Inter-DD_FG-APE) region. In the same study, we obtained an 
antibody against he IDA region that can immunoprecipitate 
c-Src and make it constitutively active. The IDA region re- 
sides in between the conserved sequence motifs in the kinase 
subdomains VII (DFG) and VIII (APE), and its sequence is 
highly specific to each protein kinase family [11]. Thus, we 
proposed that the IDA region might be generally involved 
in the regulation of protein kinase activity and that the use 
of anti-IDA antibody will allow us to perform an in vitro 
activation of certain protein kinases [10]. In the present study, 
we have utilized synthetic IDA peptides of PKA and anti-IDA 
antibodies to examine whether the IDA region of PKA is 
involved in the regulation of PKA activity. The results ob- 
tained indicate that the anti-IDA antibodies make PKA con- 
stitutively active and that there exists a direct binding between 
the IDA region of the C-subunit and a site of the R-subunit 
which is distinct from the substrate site. 
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2. Materials and methods 
2.1. Materials 
[y-a2P]ATP (35020) was obtained from ICN. cAMP, Kemptide 
(LRRASLG), and PKA-specific inhibitor peptide (PKI) were the pro- 
ducts of Sigma. Sulfosuccinimidobiotin was purchased from Pierce. 
Protein A-Sepharose was obtained from Pharmacia LKB Biotechnol- 
ogy. Avidin-biotin complex-conjugated alkaline phosphatase kit was 
from Vector Laboratories. Other reagents of analytical grade were 
obtained from Wako (Osaka) or Nacalai (Kyoto). 
2.2. Peptides and antibodies 
The following peptides (aligned in Fig. 1) were synthesized and 
purified according to the method described previously [10]: IDA1 
(FAKRVKGRTWTLCGTPDYIC), IDA2 (FAKRVKGRTWTLC), 
CTC (CIRVSINEKCGKEFSEF), and IDA-PKC (MCKENMMDG- 
VTTRTFCGTPDYIC). IDA1, IDA2, and CTC correspond to resi- 
dues 187-205, 187-199, and 335-350 of the bovine PKA C-subunit 
[12], respectively. IDA-PKC corresponds to residues 484-505 of the 
rat protein kinase C (PKC) cx [13]. The underlined Asp and Ile of 
IDA1 were introduced in place of the original residues (Glu and Leu, 
respectively) of the bovine PKA, so that the carboxyl-terminal half of 
the IDA1 coincides with the sequence of IDA-PKC. The underlined 
Asn in IDA-PKC is originally His in the rat PKCct and was replaced 
by Asn of the rat PKCI3 [14] for the convenience of peptide synthesis. 
All peptides except IDA2, which has Cys in its original carboxyl- 
terminus, were synthesized with an additional Cys in their carboxyl- 
or amino-terminus for convenience of immunization. A myelin basic 
protein peptide, MBPa_14 (QKRPSQRSKYL), was synthesized as de- 
scribed previously [15]. Rabbit antisera against IDA1, IDA2, and 
CTC were prepared according to the method of Kishimoto et al. 
[16], and the IgG fraction was purified as described previously [10]. 
Biotin-labeled anti-CTC antibody was prepared by incubating the 
purified IgG (1 mg) with 0.4 mg of sulfosuccinimidobiotin in 0.5 ml 
of 50 mM sodium phosphate buffer (pH 8.5) at room temperature for 
2 h. The coupling reaction was terminated by the addition of 50 I.tl of 
1 M Tris-HCl (pH 7.5), and the labeled antibody was dialyzed against 
17.5 mM sodium phosphate buffer (pH 6.3) and used for immunoblot 
analysis. 
2.3. Preparation of C- and R-subunits 
The C- and R-subunits of PKA type II were purified from bovine 
heart according to the methods of Beavo et al. [17] and Dills et al. 
[18], respectively. Specific activity of the purified C-subunit was 930 
nmol/min per mg under our standard assay conditions. One unit of C- 
subunit activity was defined as the amount of enzyme that catalyzes 
the transfer of 10 pmol of phosphate from ATP to Kemptide per min 
at 30°C. A half unit of R-subunit was defined as the amount of R- 
subunit hat inhibits one unit of C-subunit o 50% of the initial ac- 
tivity. The half inhibition concentration f R-subunit for 10.8 nM C- 
subunit (1.0 unit in 25/.tl of the reaction mixture) was 8.8 nM (9.9 ng/ 
25 p-l). 
2.4. Immunoprecipitation 
Immunoprecipitation of the C-subunit was carried out by incubat- 
ing an aliquot (20 p.1) of C-subunit (5 units) with 2 tll of antiserum at 
4°C for 2 h. Immune complexes were adsorbed onto 10 p-1 of protein 
A-Sepharose, washed twice with IP buffer [1% Triton X-100 and 50 
mM Tris-HC1 (pH 7.5)], and once with 50 mM Tris-HC1 (pH 7.5). 
The washed immunoprecipitate was then subjected to the kinase assay 
(see below). Immunoprecipitated C-subunit for immunoblot analysis 
was prepared by incubating 50 units of C-subunit and 10 p-1 of anti- 
serum in total 200 I11 of sodium phosphate buffer (pH 7.5) at 40C for 
2h.  
2.5. Kinase assay 
Kinase assay of the C-subunit was carried out in the standard 
reaction mixture (25 p.1) containing 50 mM Tris-HC1 (pH 7.5), 5 mM 
MgC12, 10 p-M [?-32P]ATP (6.7 Bq/pmol), 100 I.tM Kemptide, and the 
immunoprecipitated or nonprecipitated C-subunit. The reaction pro- 
ceeded at 30°C for 10 min and was stopped by the addition of SDS- 
sample buffer [19] followed by boiling for 3 min. Phosphorylated 
Kemptide was separated by SDS-polyacrylamide g l electrophoresis 
(SDS-PAGE) using 20% polyacrylamide gel. The gel was dried with- 
out staining, and the radioactivity of the specific band was analyzed 
by a BAS2000 Bioimaging Analyzer (Fujifilm, Tokyo). 
2.6. Immunoblot analysis 
Immunoprecipitated proteins were separated by SDS-PAGE using 
12.5% polyacrylamide gel and transferred to a polyvinylidene difluor- 
ide membrane (Millipore) by using a semi-dry blotter (Sartorius). The 
membrane was soaked in T-TBS [20 mM Tris-HC1 (pH 7.5), 150 mM 
NaC1, and 0.05% Tween 20] containing 1% skim milk for 1 h, and 
incubated with 10 p-g/ml biotin-labeled anti-CTC antibody in T-TBS 
containing 1% skim milk at room temperature for 2 h. After washing 
with T-TBS, the membrane was incubated with avidin-biotin complex- 
conjugated alkaline phosphatase in T-TBS at room temperature for 
2 h. To detect he immune complex, 5-bromo-4-chloro-3-indolylpho- 
sphate p-toluidine salt (50 p-g/ml) was used as substrate in the reaction 
mixture containing 100 mM Tris-HCl (pH 9.5), 100 mM NaC1, 5 mM 
MgC12, and 150 p-g/ml nitroblue tetrazolium. 
2. 7. Resonance mirror analysis 
Resonance mirror analysis [20] of the interaction between IDA 
peptides and the R-subunit was performed by using an IAsys cuvette 
system (Fisons). A cuvette with an aminosilane surface was washed 
with 10 mM sodium phosphate buffer (pH 7.7), and the surface was 
activated with 200 t.tl of 1 mM bis(sulfosuccinimidyl)suberate for 10 
min, followed by extensive washing with sodium phosphate buffer. R- 
subunit (50 p-g/ml) in 200 ~tl of 50 mM sodium acetate buffer (pH 4.0) 
was immobilized onto the surface at 20°C for 10 min. Immobilized R- 
subunit gave a signal of 465 arc seconds (465°/3600) after washing the 
cuvette with the sodium phosphate buffer. The surface was then 
blocked by incubation with 200 p-1 of 2 mg/ml bovine serum albumin 
(Calbiochem) for 5 min. Finally, the cuvette was extensively washed 
with IAsys buffer [10 mM Hepes-NaOH (pH 7.4), 150 mM NaCI, 3.4 
mM EDTA, and 0.05% Tween 20]. Association of various IDA pep- 
tides onto the surface was measured in the IAsys buffer at 20°C, and 
the surface was regenerated with 10 mM HC1 for 2 min after each 
binding experiment. Kinetic constants were determined by using the 
FAST Fit program (Fisons). 
3. Results and discussion 
3.1. Anti-IDA antibodies inhibit holoenzyme formation without 
affecting the catalytic activity of  C-subunit 
To investigate the role of the PKA IDA region lying be- 
tween kinase subdomains VII  and VII I  (Fig. 1), we have 
raised antibodies against this region. Two synthetic PKA 
IDA peptides, IDA1 and IDA2, were employed as antigens. 
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Fig. l. Schematic structure of the C-subunit and amino acid se- 
quences of synthetic peptides. The structure of the bovine PKA C- 
subunit is shown with the amino acid sequence of the IDA ~nter- 
DFG-APE) region lying between kinase subdomains VII (DFG) and 
VIII (APE). In comparison, the IDA sequence of rat PKCtx is also 
shown. IDA1 and IDA-PKC correspond to the entire IDA region 
of PKA and PKC, respectively, and share the carboxyl-terminal se- 
quence. The shared sequence is deleted in IDA2. CTC peptide cor- 
responds to the carboxyl-terminal region of C-subunit. Underlined 
amino acids were substituted and italics represent additional cy- 
steines attached for the convenience of immunization as described in 
section 2. 
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Fig. 2. Anti-IDA antibodies interfere with holoenzyme formation 
without affecting the C-subunit activity. (A) Immunoblot analysis of 
immunoprecipitated C-subunit. C-subunit (50 units) was immuno- 
precipitated with 10 ILl of anti-IDA1 (lane 1), anti-IDA2 (lane 2), or 
anti-CTC (lane 3) antiserum. The immunoprecipitates w re subjected 
to immunoblot analysis with biotin-labeled anti-CTC antibody to- 
gether with the control C-subunit (2.5 units, lane 4). The position 
of the C-subunit is indicated by an arrowhead. Prestained molecular 
size markers (Bio-Rad): phosphorylase b (106 kDa), bovine serum 
albumin (80 kDa), ovalbumin (49.5 kDa), carbonic anhydrase (32.5 
kDa), soybean trypsin inhibitor (27.5 kDa), and lysozyme (18.5 
kDa). (B) Phosphorylation f Kemptide by immunoprecipitated C- 
subunit. Immunoprecipitation was carried out by incubating C-sub- 
unit (5 units) with 2 ~tl of either anti-IDA1 (top), anti-IDA2 (mid- 
die), or anti-CTC (bottom) antiserum which had been preincubated 
at 4°C for 1 h in the absence (lane 1) or presence of 50 taM syn- 
thetic peptides, IDA1 (lane 2), IDA2 (lane 3), IDA-PKC (lane 4), 
or CTC (lane 5). Immunoprecipitates w re subjected to kinase assay 
as described in section 2. Phosphoimage of 32P-Kemptide was ana- 
lyzed by BAS2000 Bioimaging Analyzer (Fuji film, Tokyo). (C) Ef- 
fect of anti-IDA antibodies on holoenzyme formation. Immunopre- 
cipitaion of C-subunit with either anti-IDA1 (lanes 1-3), anti-IDA2 
(lanes 4-6), or anti-CTC (lanes 7-9) antiserum was carried out as in 
(B). The immunoprecipitates w re incubated on ice for 10 rain in 
the absence (lanes 1,4,7) or presence (lanes 2,3,5,6,8,9) of R-subunit 
(1 unit), washed extensively, and subjected to kinase assay in the 
absence (lanes 1,2,4,5,7,8) or presence (lanes 3,6,9) of 1 p~M cAMP. 
Since the carboxyl-terminal sequence of the IDA region is 
highly conserved among PKA and PKC molecules from var- 
ious species [11], IDA-PKC was prepared to cover the entire 
IDA region of PKC and used as a control peptide. IDA1 was 
synthesized so that it coincides with the IDA region of PKC 
in its carboxyl-terminus. The shared sequence was deleted in 
IDA2, thus it corresponds to the IDA region specific to PKA. 
We also prepared a synthetic peptide, named CTC, which 
corresponds to the carboxyl-terminus of the C-subunit as a 
control antigen (Fig. 1). 
Antibodies against he synthetic IDA peptides (anti-IDA1 
and anti-IDA2) and a control antibody against he CTC pep- 
tide (anti-CTC) were prepared and characterized. The reactiv- 
ity and specificity of these anti-peptide antibodies are shown 
in Fig. 2. Immunoprecipitation and immunoblot analysis re- 
vealed that a nearly equal amount of C-subunit was irnmuno- 
precipitated with each antibody (Fig. 2A). In Fig. 2B, the 
kinase activity of these immunoprecipitates was examined by 
using Kemptide as substrate. It is shown that a similar kinase 
activity was detected with each immunoprecipitate (lane 1), 
indicating that the kinase activity of the C-subunit is not 
affected by the anti-IDA antibodies. Fig. 2B also shows the 
results of epitope analysis of the antibodies. Anti-IDAl and 
anti-IDA2 reacted with both IDA1 (lane 2) and IDA2 (lane 
3), but not with IDA-PKC (lane 4) or CTC (lane 5). Reactiv- 
ity of anti-CTC antibody towards the carboxyl-terminal pep- 
tide was also confirmed (Fig. 2B, lower panel). 
We next examined whether the C-subunit immunoprecipi- 
tated with anti-IDA antibodies i able to form a holoenzyme 
complex with the R-subunit. This experiment was performed 
as follows, lmmunoprecipitates of the C-subunit prepared as 
in Fig. 2B were first incubated with an excess amount of the 
R-subunit. After incubation, immunoprecipitates w re washed 
to remove unbound R-subunit, and then subjected to kinase 
assay in the presence or absence of cAMP. As shown in Fig. 
2C, kinase activity of both anti-IDA1 (lane 2) and anti-IDA2 
(lane 5) immunoprecipitates was not inhibited by preincuba- 
tion with the R-subunit. On the other hand, the kinase activ- 
ity of anti-CTC immunoprecipitate was clearly inhibited by 
preincubation with the R-subunit (lane 8), compared with the 
control activity observed without he R-subunit (lane 7) or in 
the presence of cAMP (lane 9). These results indicate that the 
R-subunit cannot form a stable complex with the C-subunit 
immunoprecipitated with anti-IDA antibodies, while the anti- 
CTC immunoprecipitate is able to form a holoenzyme. 
3.2. Anti-IDA antibodies reduce the susceptibility of the C-sub- 
unit to inhibition by the R-subunit, but not by PK1 
The finding that anti-IDA antibodies inhibit holoenzyme 
formation suggested that these antibodies may distort he reg- 
ulation of the C-subunit by the R-subunit. Thus, we examined 
the kinase activity of immunoprecipitates in the presence of 
various amounts of R-subunit. As shown in Fig. 3A, the effect 
of both anti-IDA1 and anti-IDA2 antibodies was observed as 
a reduced susceptibility of the C-subunit to inhibition by the 
R-subunit, whereas the control anti-CTC antibody had vir- 
tually no effect. Importantly, however, anti-IDA antibodies 
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Fig. 3. Effect of R-subunit and PKI on C-subunit activity immuno- 
precipitated with anti-IDA antibody. Immunoprecipitation of C-sub- 
unit with anti-IDA1 (e), anti-IDA2 (~,), or anti-CTC (O) antiserum 
was carried out as in Fig. 2B. The immunoprecipitated or non-pre- 
cipitated C-subunit (0.1 units, ×) was subjected to kinase assay in 
the presence of the indicated amounts of R-subunit (A) or PKI (B). 
Phosphorylation f Kemptide was quantified as described in section 
2. 100% values: anti-IDA1 immunoprecipitate, 4630 PSL; anti- 
IDA2 immunoprecipitate, 3380 PSL; anti-CTC immunoprecipitate, 
4640 PSL; nonprecipitated C-subunit, 4090 PSL. 
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Fig. 4. Resonance mirror analysis of the interaction between IDA peptides and R-subunit. Association of IDA1 (A) or IDA2 (B) with the im- 
mobilized R-subunit on the aminosilane surface was analyzed by the IAsys cuvette system as described in section 2. Response is recorded as a 
change in the resonance angle and represented in arc seconds which is proportional to the amount of peptides associated with the R-subunit. 
As a control, IDA-PKC (10 ~tM) was used instead of IDA1 or IDA2. (C) Plots of Ko~ (the on-rate constants for particular concentrations of 
peptides) against he concentrations of IDA1 (e) and IDA2 ((3) were performed by using the FAST fit program, k~ (the slope) and the kdiss 
(the extrapolated intercept on the y-axis) were obtained from the plots. Kd = kdiss/kass 
could not completely abolish the inhibitory effect of the R- 
subunit on the C-subunit, indicating that the R-subunit is able 
to interact with the C-subunit through a site distinct from the 
IDA region which is blocked by the anti-IDA antibodies. This 
was confirmed in the experiment using PKI, a PKA-specific 
inhibitor peptide, which has a pseudosubstrate site similar to 
the substrate site of the R-subunit [21]. In this case, the con- 
centration-dependent inhibition of the activity of anti-IDA 
immunoprecipitates followed that of nonprecipitated or anti- 
CTC-immunoprecipitated C-subunit (Fig. 3B). The result in- 
dicates that the pseudosubstrate site of PKI interacts with a 
site which is different from the IDA region of the C-subunit, 
and therefore suggests that the interaction site of IDA region 
in the holoenzyme is different from the substrate site of the R- 
subunit. The present observation is also quite consistent with 
the results obtained from molecular biological studies [7,8]. 
3.3. IDA1 and IDA2 peptides can bind to R-subunit 
Further evidence for the participation of the IDA region in 
the process of holoenzyme formation was obtained by the use 
of resonance mirror analysis [20]. This enabled direct mea- 
surement of IDA peptide binding to the R-subunit. Fig. 4 
shows a dose-dependent association of IDA1 (panel A) or 
IDA2 (panel B) with the R-subunit which was immobilized 
onto the aminosilane surface. The binding is believed to be 
specific, because (1) both IDA1 and IDA2 did not bind to the 
surface on which the C-subunit was immobilized, and (2) a 
basic peptide MBP,~14, which is derived from myelin basic 
protein and has a similar pI (pI 11.6) to that of IDA1 (pI 
9.5) or IDA2 (pI 11.5), did not bind to the surface on which 
the R-subunit (pI 4.7) was immobilized (data not shown). 
Moreover, IDA-PKC, which shares the same sequence with 
IDA1 in the carboxyl-terminus, did not bind to the immobi- 
lized R-subunit (Fig. 4A,B). This observation i dicates that 
the above association is taking place through the IDA2 re- 
gion. 
The stoichiometry of IDA peptide binding to the immobi- 
lized R-subunit was calculated from the data for 10 ~tM and 
found to be 1.0 mol/mol of R-subunit for IDA1 and 1.3 mol/ 
mol for IDA2. The binding curves, shown as an overlay plot, 
were analyzed by the FAST Fit program (Fisons) to de- 
termine the kinetic constants of binding (Fig. 4C). The asso- 
ciation rate constants of IDA1 (k~s = 1.3× 104 M -1 s -1) and 
IDA2 (3.3 × 104 M -1 s -1) were quite high and close to that of 
holoenzyme formation of the C-subunit with R-subunit type I 
(ka~s = 1.0× 105 M -1 s -1) previously reported by Herberg et 
al. [5]. In contrast, kdiss (IDA1, 6.0×10 -2 s- l ;  IDA2, 
6.0X10 -2 s - i)  and Kd (IDA1, 4.6×10 -6 M; IDA2, 
1.8 X 10 -6 M) were significantly different from those of the 
holoenzyme formation (kdi~ = 2.3 × 10 -5 s -1 and 
Kd = 2.3 × 10 -1° M) [5]. The values of the constants indicate 
that the binding of IDA peptides to the R-subunit is fast but 
rather unstable. 
It is evident hat the affinity of IDA peptide to the R-sub- 
unit is not sufficient to support a stable complex between the 
R- and C-subunits. Since the binding of substrate seems to be 
independent of the IDA-mediated interaction (Fig. 3), it is 
likely that interactions through both sites (substrate binding 
site and IDA region) are necessary to achieve fficient binding 
of the C-subunit to the R-subunit. Considering the high asso- 
ciation constant of IDA peptides with the R-subunit, we spec- 
ulate that the IDA2 region may take part in the initial stage of 
holoenzyme formation, helping to settle the substrate site of 
the R-subunit o the substrate binding site of the C-subunit. 
Identification of the interaction site of IDA2 peptide within 
the R-subunit will provide further information on this dual 
mode of interaction between the C- and R-subunits. 
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